A Decision Model of Therapy for Potentially Resectable Pancreatic Cancer

Journal of Surgical Research - United States
doi 10.1016/j.jss.2011.08.022
Full Text
Abstract

Available in full text

Categories
Surgery
Date
Authors
Publisher

Elsevier BV

Related search

Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer: A Meta-Analysis of Randomized Controlled Trials

Journal of Clinical Medicine
2020English

Clinicodemographic Aspect of Resectable Pancreatic Cancer and Prognostic Factors for Resectable Cancer

World Journal of Surgical Oncology
SurgeryOncology
2012English

Folfirinox Neoadjuvant Therapy for Locally Advanced and Borderline Resectable Pancreatic Cancer - A Retrospective Study

International Journal of Contemporary Medical Research [IJCMR]
2019English

Borderline Resectable Pancreatic Cancer: Definitions and the Importance of Multimodality Therapy

Annals of Surgical Oncology
OncologySurgery
2010English

Management of Borderline Resectable Pancreatic Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2018English

Neoadjuvant FOLFIRINOX for Patients With Borderline Resectable or Locally Advanced Pancreatic Cancer: Results of a Decision Analysis

Oncologist
Cancer ResearchMedicineOncology
2019English

Preoperative Predictors for Early Recurrence of Resectable Pancreatic Cancer

World Journal of Surgical Oncology
SurgeryOncology
2017English

Cutting‐edge Strategies for Borderline Resectable Pancreatic Cancer

Annals of Gastroenterological Surgery
2019English

Pancreatic Cancer Is ‘Always Non-Resectable’

Digestive Diseases
MedicineGastroenterology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy